Tarsons Products Limited (NSE:TARSONS)
312.95
-2.65 (-0.84%)
Sep 12, 2025, 3:29 PM IST
Tarsons Products Revenue
Tarsons Products had revenue of 913.64M INR in the quarter ending June 30, 2025, with 7.74% growth. This brings the company's revenue in the last twelve months to 3.99B, up 25.22% year-over-year. In the fiscal year ending March 31, 2025, Tarsons Products had annual revenue of 3.92B with 32.40% growth.
Revenue (ttm)
3.99B
Revenue Growth
+25.22%
P/S Ratio
4.17
Revenue / Employee
4.85M
Employees
823
Market Cap
16.65B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 3.92B | 960.20M | 32.40% |
Mar 31, 2024 | 2.96B | 131.46M | 4.64% |
Mar 31, 2023 | 2.83B | -175.46M | -5.83% |
Mar 31, 2022 | 3.01B | 694.77M | 30.04% |
Mar 31, 2021 | 2.31B | 563.32M | 32.19% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Alkem Laboratories | 133.04B |